Stemsynergy Therapeutic
Miami, FL · Biotech · Private
SSTN-302, a first-in-class selective Notch1 transcriptional complex inhibitor for esophageal adenocarcinoma
- Grants
- $5.8M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a WNT Inhibitor for Regenerative Healing of Burn Injuries | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development Of A Wnt Pathway Inhibitor For Metastatic Colorectal Cancer | $2,999,979 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of Notch Pathway Specific Inhibitors as Targeted Therapeutics for Cancer | $299,994 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Oral WNT inhibitor | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Notch1-selective Small Molecule Inhibitor for the Treatment of Cancer | $1,976,591 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2381 | Jaguar Health, Inc. | — | $146M |
| 2382 | MediWound Ltd. | — | $31M |
| 2383 | SALIX PHARMACEUTICALS LTD | — | $750M |
| 2384 | Stemsynergy Therapeutic | — | — |
| 2385 | HiberCell | — | — |
| 2386 | RaeSedo, LLC | — | — |
| 2387 | Rakuten Medical, Inc. | — | $887M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.